Vericel (VCEL) Operating Expenses (2010 - 2026)
Vericel's (VCEL) quarterly Operating Expenses came in at $57.3 million in Q1 2026, up 16.85% year-on-year from $49.1 million in Q1 2025, and up 13.05% quarter-over-quarter from $50.7 million in Q4 2025.
Vericel (VCEL) Operating Expenses (2010 - 2026) Analysis & Trends
Vericel has disclosed Operating Expenses across 17 years of filings, most recently posting $57.3 million for Q1 2026.
- Operating Expenses for Q1 2026 came in at $57.3 million, up 16.85% year-over-year; the trailing twelve-month figure through Mar 2026 was $202.8 million (up 15.35% YoY), and the FY2025 annual result was $194.6 million, up 16.09% from the prior year.
- Operating Expenses came in at $57.3 million for Q1 2026 at Vericel, up from $50.7 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $57.3 million in Q1 2026 to a low of $30.7 million in Q1 2022.
- The 5-year median for Operating Expenses is $40.0 million (2024), against an average of $40.5 million.
- Across the five-year window, Operating Expenses gained 4.23% in 2022 and rose 26.72% in 2025, its largest moves.
- Vericel's Operating Expenses stood at $32.2 million in 2022, then gained by 11.23% to $35.8 million in 2023, then increased by 11.86% to $40.0 million in 2024, then rose by 26.72% to $50.7 million in 2025, then gained by 13.05% to $57.3 million in 2026.
- The last three Operating Expenses figures came in at $57.3 million (Q1 2026), $50.7 million (Q4 2025), and $46.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 4.33 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 32.68 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -138.30 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.82 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 15.76 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 574,669.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.85 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -67.40 Mn |
| 10 | Vericel | 2.04 Bn | 1.90 Bn | 49.27 Mn | 57.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 57.33 Mn |
| Dec 31, 2025 | 50.71 Mn |
| Sep 30, 2025 | 46.14 Mn |
| Jun 30, 2025 | 48.64 Mn |
| Mar 31, 2025 | 49.07 Mn |
| Dec 31, 2024 | 40.02 Mn |
| Sep 30, 2024 | 44.12 Mn |
| Jun 30, 2024 | 42.63 Mn |
| Mar 31, 2024 | 40.82 Mn |
| Dec 31, 2023 | 35.78 Mn |
| Sep 30, 2023 | 35.67 Mn |
| Jun 30, 2023 | 35.90 Mn |
| Mar 31, 2023 | 34.70 Mn |
| Dec 31, 2022 | 32.16 Mn |
| Sep 30, 2022 | 32.02 Mn |
| Jun 30, 2022 | 31.94 Mn |
| Mar 31, 2022 | 30.73 Mn |
| Dec 31, 2021 | 29.89 Mn |
| Sep 30, 2021 | 27.06 Mn |
| Jun 30, 2021 | 30.64 Mn |